QQQ   414.73 (-2.05%)
AAPL   165.11 (-1.16%)
MSFT   399.28 (-1.23%)
META   479.55 (-4.43%)
GOOGL   153.82 (-1.40%)
AMZN   174.34 (-2.72%)
TSLA   146.98 (-1.97%)
NVDA   769.00 (-9.18%)
AMD   146.18 (-5.74%)
NIO   3.81 (-4.75%)
BABA   69.05 (+0.25%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   106.48 (-4.87%)
GE   148.44 (-2.94%)
CGC   8.05 (+2.81%)
DIS   112.31 (-0.11%)
AMC   3.13 (+7.19%)
PFE   25.96 (+2.24%)
PYPL   61.96 (-0.23%)
XOM   119.97 (+1.22%)
QQQ   414.73 (-2.05%)
AAPL   165.11 (-1.16%)
MSFT   399.28 (-1.23%)
META   479.55 (-4.43%)
GOOGL   153.82 (-1.40%)
AMZN   174.34 (-2.72%)
TSLA   146.98 (-1.97%)
NVDA   769.00 (-9.18%)
AMD   146.18 (-5.74%)
NIO   3.81 (-4.75%)
BABA   69.05 (+0.25%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   106.48 (-4.87%)
GE   148.44 (-2.94%)
CGC   8.05 (+2.81%)
DIS   112.31 (-0.11%)
AMC   3.13 (+7.19%)
PFE   25.96 (+2.24%)
PYPL   61.96 (-0.23%)
XOM   119.97 (+1.22%)
QQQ   414.73 (-2.05%)
AAPL   165.11 (-1.16%)
MSFT   399.28 (-1.23%)
META   479.55 (-4.43%)
GOOGL   153.82 (-1.40%)
AMZN   174.34 (-2.72%)
TSLA   146.98 (-1.97%)
NVDA   769.00 (-9.18%)
AMD   146.18 (-5.74%)
NIO   3.81 (-4.75%)
BABA   69.05 (+0.25%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   106.48 (-4.87%)
GE   148.44 (-2.94%)
CGC   8.05 (+2.81%)
DIS   112.31 (-0.11%)
AMC   3.13 (+7.19%)
PFE   25.96 (+2.24%)
PYPL   61.96 (-0.23%)
XOM   119.97 (+1.22%)
QQQ   414.73 (-2.05%)
AAPL   165.11 (-1.16%)
MSFT   399.28 (-1.23%)
META   479.55 (-4.43%)
GOOGL   153.82 (-1.40%)
AMZN   174.34 (-2.72%)
TSLA   146.98 (-1.97%)
NVDA   769.00 (-9.18%)
AMD   146.18 (-5.74%)
NIO   3.81 (-4.75%)
BABA   69.05 (+0.25%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   106.48 (-4.87%)
GE   148.44 (-2.94%)
CGC   8.05 (+2.81%)
DIS   112.31 (-0.11%)
AMC   3.13 (+7.19%)
PFE   25.96 (+2.24%)
PYPL   61.96 (-0.23%)
XOM   119.97 (+1.22%)
Free Trial
NYSEARCA:SBIO

ALPS Medical Breakthroughs ETF (SBIO) Price, Holdings, & News

→ Strange new buyer driving up gold (From Stansberry Research) (Ad)
Free SBIO Stock Alerts
$31.40
-0.41 (-1.29%)
(As of 01:52 PM ET)
Compare
Today's Range
$31.38
▼
$31.76
50-Day Range
$31.81
▼
$38.69
52-Week Range
$23.21
▼
$38.80
Volume
49,013 shs
Average Volume
12,420 shs
Market Capitalization
$100.48 million
Assets Under Management
$101.73 million
Dividend Yield
0.21%
Net Expense Ratio
0.50%
Stock AnalysisChartHeadlinesHoldingsOwnershipRatings
SBIO stock logo

About ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.

SBIO Stock Price History

SBIO ETF News Headlines

April 17, 2024 | finance.yahoo.com
ALPS Medical Breakthroughs ETF (SBIO)
February 22, 2024 | benzinga.com
ALPS ETF Trust ALPS Intermediate Municipal Bond ETF (ARCA:MNBD) Dividends: History, Yield and Dates
April 19, 2024 | Stansberry Research (Ad)
Strange new buyer driving up gold
One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."
February 11, 2024 | msn.com
I checked into a £40,000-a-week rehab in the Swiss Alps
January 19, 2024 | seekingalpha.com
How ETF Investors Can Take Advantage Of Deal Activity
December 30, 2023 | finance.yahoo.com
Biotech ETF SBIO’s Momentum Strong to End 2023
December 22, 2023 | msn.com
ALPS Medical Breakthroughs ETF declares annual distribution of $0.0711
December 10, 2023 | finance.yahoo.com
Play US Gene Treatment Approval in SBIO
April 19, 2024 | Stansberry Research (Ad)
Strange new buyer driving up gold
One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."
September 12, 2023 | finance.yahoo.com
SBIO - ALPS Medical Breakthroughs ETF
See More Headlines
Receive SBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ALPS Medical Breakthroughs ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
ALPS
Fund Name
ALPS Medical Breakthroughs ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:SBIO
Inception Date
12/31/2014
Fund Manager
Ryan Mischker, Andrew Hicks
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
S-Network Medical Breakthroughs Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
97

Fund Statistics

Assets Under Management
$101.73 million
Average Daily Volume
$9,902.00
Discount/Premium
0.02%

Administrator, Advisor and Custodian

Administrator
ALPS Fund Services, Inc.
Advisor
ALPS Advisors, Inc.
Custodian
State Street Bank and Trust Company
Distributor
ALPS Portfolio Solutions Distributor, Inc.
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
GTS

Options

Optionable
Optionable
Options Volume
17
Put Options
1
Call Options
16
Short Interest
12,300 shs

Miscellaneous

Outstanding Shares
3,200,000
Beta
1.03
Creation Unit
50,000
Creation Fee
$500.00
5G Stocks: The Path Forward is Profitable Cover
5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Ad Stansberry Research
Strange new buyer driving up gold
One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."
But there's a much better move you can make to get in front of these big moves today.

ALPS Medical Breakthroughs ETF Expenses

TypeSBIOHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.50%0.56%0.54%0.50%0.51%
Other Expenses0.00%0.40%0.54%0.64%0.58%
Total Expense0.50%0.72%0.70%0.74%0.70%
Fee Waiver0.00%-0.53%-0.55%-0.68%-0.57%
Net Expense0.50%0.60%0.60%0.58%0.58%

ALPS Medical Breakthroughs ETF (SBIO) Holdings & Exposure

Top 10 SBIO Holdings

SBIO Sector Exposure

SBIO Industry Exposure

Full Holdings Details

SBIO ETF - Frequently Asked Questions

How have SBIO shares performed in 2024?

ALPS Medical Breakthroughs ETF's stock was trading at $32.94 at the beginning of 2024. Since then, SBIO shares have decreased by 4.7% and is now trading at $31.40.
View the best growth stocks for 2024 here.

What does SBIO invest in?

ALPS Medical Breakthroughs ETF is a equity fund issued by ALPS. SBIO focuses on health care investments and follows the S-Network Medical Breakthroughs Index. The fund's investments total to approximately $101.73 million assets under management.

What stocks does ALPS Medical Breakthroughs ETF hold?

SBIO invests in 97 holdings. Some of the stocks in their portfolio include Cerevel Therapeutics (CERE), Viking Therapeutics (VKTX), Vaxcyte (PCVX), Revolution Medicines (RVMD), Alpine Immune Sciences (ALPN), Alkermes (ALKS), Crinetics Pharmaceuticals (CRNX), Axsome Therapeutics (AXSM), SpringWorks Therapeutics (SWTX) and Xenon Pharmaceuticals (XENE).

What is the management fee for ALPS Medical Breakthroughs ETF?

ALPS Medical Breakthroughs ETF's management fee is 0.50% and has no other recorded expenses or fee waivers. The net expense ratio for SBIO is 0.50%.

What other stocks do shareholders of ALPS Medical Breakthroughs ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ALPS Medical Breakthroughs ETF investors own include Micron Technology (MU), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Johnson & Johnson (JNJ), Novavax (NVAX), Alibaba Group (BABA), Cidara Therapeutics (CDTX) and Quest Diagnostics (DGX).

Who are ALPS Medical Breakthroughs ETF's major shareholders?

ALPS Medical Breakthroughs ETF's stock is owned by many different retail and institutional investors. Top institutional investors include Central Valley Advisors LLC (0.18%).

How do I buy shares of ALPS Medical Breakthroughs ETF?

Shares of SBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:SBIO) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media
My biggest AI fear
Paradigm Press